These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35903283)

  • 1. The Mysterious Universe of the TSH Receptor.
    Vieira IH; Rodrigues D; Paiva I
    Front Endocrinol (Lausanne); 2022; 13():944715. PubMed ID: 35903283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrathyroidal expression of TSH receptor.
    Williams GR
    Ann Endocrinol (Paris); 2011 Apr; 72(2):68-73. PubMed ID: 21511243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.
    Carayanniotis G; Huang GC; Nicholson LB; Scott T; Allain P; McGregor AM; Banga JP
    Clin Exp Immunol; 1995 Feb; 99(2):294-302. PubMed ID: 7851025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY.
    Kahaly GJ; Diana T; Olivo PD
    Endocr Pract; 2020 Jan; 26(1):97-106. PubMed ID: 32022598
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin in teleost fish.
    MacKenzie DS; Jones RA; Miller TC
    Gen Comp Endocrinol; 2009 Mar; 161(1):83-9. PubMed ID: 19135445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
    Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
    J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y; Ishihara T; Ikekubo K; Mori T
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum unmasks the binding of thyroid-stimulating hormone to endogenous and transfected receptors: evidence for a soluble form of the receptor in human thyroid.
    Willey KP; Hunt N; Abend N; Northemann W; Ivell R; Leidenberger F
    J Endocrinol; 1993 Nov; 139(2):317-28. PubMed ID: 8308468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y; Hamazu M; Kajita Y; Nagata A
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S; Ban T; Kohn LD
    Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of thyroidal and extrathyroidal thyrotropin receptors.
    Hoermann R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():88-91. PubMed ID: 8981010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of thyroid-stimulating hormone receptors and thyroglobulin in limbic regions in the adult human brain.
    Naicker M; Naidoo S
    Metab Brain Dis; 2018 Apr; 33(2):481-489. PubMed ID: 28776278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of serum TSH by Graves' Ig: evidence for a functional pituitary TSH receptor.
    Brokken LJ; Scheenhart JW; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4814-7. PubMed ID: 11600546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.